tirzepatide cardiovascular outcomes trial results july 2025 Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT Reduction of prevalence of patients

doi:10.3892/or_00000144

While Ozempic is approved for Type 2 diabetes, Wegovy is approved for weight loss in people ages 12 years and older with obesity and in adults who are overweight with a weight-related health condition

Several clinical trials are currently underway or recently completed, though published results remain limited

When To Call a Professional Make an appointment to see a health care professional if you have significant heel pain that does not improve within a few days

Lose Weight with Natural GLP-1 Boosters According to a recent survey, about 50% of Americans are currently trying to lose weight

Umapathy, A., Li, B., Donaldson, P